Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-322.98M
↓ 184% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-113.60M
Historical baseline
PeriodValueYoY Change
2025$-322.98M-17.5%
2024$-274.90M-71.2%
2023$-160.60M-20.1%
2022$-133.68M-558.9%
2021$29.13M+140.9%
2020$-71.26M-40.8%
2019$-50.61M+26.1%
2018$-68.53M-44.7%
2017$-47.37M-34.7%
2016$-35.16M-